Daniel Carey Cazel Hood
Directeur/Bestuurslid bij Intercept Pharma Europe Ltd.
Oorsprong van het eerstegraads netwerk van Daniel Carey Cazel Hood
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Daniel Carey Cazel Hood via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Founder | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Investment Managers | Corporate Officer/Principal | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
| McGill University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
| Montclair State University | College/University | Undergraduate Degree | |
| McMaster University | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University College London | College/University | Undergraduate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Founder | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| Foundation for the Defense of Democracies | Director/Board Member | ||
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
| Paul H. Nitze School of Advanced International Studies (IT) | College/University | Graduate Degree | |
| Gilead Sciences Ireland UC | Corporate Officer/Principal | ||
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | ||
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Pharmaceuticals BV
 Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Pharmaceuticals: Major | Director of Finance/CFO | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Corporate Officer/Principal | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | Medical Distributors | Director/Board Member | |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Director/Board Member | |
| Johns Hopkins University School of Advanced International | College/University | Graduate Degree | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Biotechnology | Chief Executive Officer | |
| MedicinePlanet, Inc. | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 23 |
| Verenigd Koninkrijk | 9 |
| Zwitserland | 6 |
| Canada | 4 |
| Denemarken | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 8 |
| Finance | 5 |
| Commercial Services | 4 |
| Distribution Services | 4 |
Operationeel
| Director/Board Member | 20 |
| Corporate Officer/Principal | 10 |
| Independent Dir/Board Member | 5 |
| Director of Finance/CFO | 5 |
| Chief Executive Officer | 4 |
Sterkste connecties
| Insiders | |
|---|---|
| Sandipkumar S. Kapadia | 19 |
| Mark Pruzanski | 17 |
| Lisa Bright | 13 |
- Beurs
- Insiders
- Daniel Carey Cazel Hood
- Bedrijfsconnecties
